InMode Ltd. (INMD) stock surged +2.43%, trading at $13.92 on NASDAQ, up from the previous close of $13.59. The stock opened at $13.59, fluctuating between $13.50 and $14.23 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 07, 2026 | 13.59 | 14.23 | 13.50 | 13.92 | 1.53M |
| May 06, 2026 | 13.40 | 13.62 | 13.25 | 13.59 | 1.95M |
| May 05, 2026 | 14.35 | 14.43 | 14.13 | 14.40 | 580.77K |
| May 04, 2026 | 14.33 | 14.50 | 14.28 | 14.31 | 337.91K |
| Apr 30, 2026 | 14.01 | 14.47 | 14.00 | 14.47 | 364.63K |
| Apr 29, 2026 | 14.15 | 14.15 | 13.92 | 13.96 | 371.72K |
| Apr 28, 2026 | 14.33 | 14.37 | 14.15 | 14.21 | 303.36K |
| Apr 27, 2026 | 14.40 | 14.49 | 14.31 | 14.31 | 352.43K |
| Apr 23, 2026 | 14.41 | 14.41 | 14.17 | 14.36 | 453.47K |
| Apr 22, 2026 | 14.62 | 14.71 | 14.40 | 14.41 | 408.34K |
| Apr 21, 2026 | 14.60 | 14.71 | 14.49 | 14.51 | 361.24K |
| Apr 20, 2026 | 14.55 | 14.80 | 14.53 | 14.57 | 744.61K |
| Apr 17, 2026 | 14.49 | 14.84 | 14.45 | 14.65 | 872.45K |
| Apr 16, 2026 | 14.25 | 14.38 | 14.20 | 14.33 | 1.19M |
| Apr 14, 2026 | 13.99 | 14.27 | 13.99 | 14.14 | 779.7K |
| Apr 13, 2026 | 13.70 | 14.00 | 13.61 | 13.99 | 842.64K |
| Apr 10, 2026 | 13.68 | 13.78 | 13.35 | 13.53 | 1.18M |
| Apr 09, 2026 | 13.71 | 13.84 | 13.65 | 13.69 | 764.93K |
| Apr 08, 2026 | 13.91 | 13.96 | 13.74 | 13.78 | 465.2K |
| Apr 07, 2026 | 13.69 | 13.77 | 13.60 | 13.65 | 893.04K |
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
| Employees | 599 |
| Beta | 2.19 |
| Sales or Revenue | $492.05M |
| 5Y Sales Change% | 2.761% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep